PUBLIC CONTRACT · 2025
251A000047 - Lanreotido sol inj 120 mg
- Contract value
- €10,182.00
- Signed on
- 31 March 2025
- Procedure
- Open procedure (Concurso público)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 11319168PUBLISHED SUBJECT
251A000047 - LANREOTIDO SOL INJ 120 MG
Parties involved
- Place of performance
- Portugal, Lisboa, Lisboa
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- ADVANZ PHARMA PORTUGAL, UNIPESSOAL LDA · Tax ID 513679073
Values and timeline
- Contract price
- €10,182.00
- Procedure base price
- €10,182.00
- Total effective price
- Not reported on Portal BASE
- Publication date
- 31 March 2025
- Award date
- 26 March 2025
- Signing date
- 31 March 2025
- Performance period
- 275 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Open procedure (Concurso público)
- Award criterion
- Monofator
- CPV code
- 33652200-7 - Medicamentos usados na terapêutica endócrina
- Legal basis
- Artigo 155.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- 6532/2025
- Procedure identifier
- 7515793
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.